Cargando…
Induction of DISE in ovarian cancer cells in vivo
The death receptor CD95/Fas can be activated by immune cells to kill cancer cells. shRNAs and siRNAs derived from CD95 or CD95 ligand (CD95L) are highly toxic to most cancer cells. We recently found that these sh/siRNAs kill cancer cells in the absence of the target by targeting the 3’UTRs of critic...
Autores principales: | Murmann, Andrea E., McMahon, Kaylin M., Haluck-Kangas, Ashley, Ravindran, Nandini, Patel, Monal, Law, Calvin Y., Brockway, Sonia, Wei, Jian-Jun, Thaxton, C. Shad, Peter, Marcus E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689563/ https://www.ncbi.nlm.nih.gov/pubmed/29156673 http://dx.doi.org/10.18632/oncotarget.21471 |
Ejemplares similares
-
DISE/6mer seed toxicity-a powerful anti-cancer mechanism with implications for other diseases
por: Haluck-Kangas, Ashley, et al.
Publicado: (2021) -
SPOROS: A pipeline to analyze DISE/6mer seed toxicity
por: Bartom, Elizabeth T., et al.
Publicado: (2022) -
DISE, an ancient anti-cancer mechanism that senses mutational load in cancerous cells?
por: Patel, Monal, et al.
Publicado: (2023) -
Comparing the Effectiveness and Engagement of Comics to 3D Animation in Teaching Advances in Nanomedicine
por: Gao, Angela W., et al.
Publicado: (2018) -
Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism
por: Putzbach, William, et al.
Publicado: (2017)